AJR AJR Reprints & E-prints Available. Order Today!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lim, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lim, J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
AJR 2003; 181:819-827
© American Roentgen Ray Society


Review

Cholangiocarcinoma: Morphologic Classification According to Growth Pattern and Imaging Findings

Jae Hoon Lim1

1 Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Ilwon-Dong, Kangnam-Ku, Seoul 135-710, South Korea.

Received February 10, 2003; accepted after revision March 19, 2003.

 
Address correspondence to J. H. Lim (jhlim{at}smc.samsung.co.kr).


Introduction
Top
Introduction
Pathologic and Imaging Findings
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
Mode of Spread
Clinical Significance
References
 
Cholangiocarcinoma is a malignant tumor arising from the epithelium of the bile ducts. Most of these tumors are adenocarcinomas [1]. Intrahepatic cholangiocarcinoma accounts for 10% of all cholangiocarcinomas, hilar cholangiocarcinoma for 25%, and extrahepatic cholangiocarcinoma for 65% [2, 3]. Usually, intrahepatic cholangiocarcinoma presents as a large mass because the tumor does not cause clinical symptoms in its early stages, whereas extrahepatic cholangiocarcinoma is usually small at the time of presentation because the bile ducts are occluded in its early stage and patients present with jaundice.

Various terminology and classifications have been used to describe the pathologic and radiologic appearance of cholangiocarcinoma, and each describes a specific aspect of the tumor. However, some of the terminology and classifications are ambiguous and therefore confusing. Eggel [4] classified cholangiocarcinomas as nodular, massive, and diffuse, like hepatocellular carcinoma. Rosai [5] classified cholangiocarcinoma as polypoid and sclerosing. Weinbren and Mutum [6] classified cholangiocarcinoma into three types: nodular, sclerosing, and papillary. In the radiologic literature, hilar and extrahepatic cholangiocarcinomas have been classified as exophytic, infiltrating, and polypoid (or papillary) [7-9].

The Liver Cancer Study Group of Japan has proposed a new classification based on growth characteristics, with tumors being identified as mass-forming, periductal-infiltrating, and intraductal-growing types [10] (Figs. 1A, 1B, and 1C). This classification is considered to be the most reasonable because it describes the gross appearance, growing characteristics, biologic behavior, and prognostic implication for patients [11, 12] and because it is helpful for radiologic interpretation. According to this new classification, which I use for this review article, the exophytic or nodular type matches the mass-forming type, the infiltrating or sclerosing type matches the periductal-infiltrating, and the polypoid or papillary type matches the intraductal-growing type. The prognosis for mass-forming and periductal-infiltrating cholangiocarcinomas is generally unfavorable, whereas the prognosis for intraductal-growing cholangiocarcinoma is much better (or excellent) after surgical resection [11-14]. Precise characterization of these tumors in terms of their growth pattern and staging is mandatory for optimal treatment planning and for determining a prognosis. Surgical resection should be tailored depending on the morphologic type and the stage of the tumors [10]. In this regard, the morphologic classification of cholangiocarcinoma is important.



View larger version (6K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1A. Morphologic classification of intrahepatic and extrahepatic cholangiocarcinoma. Tubule represents bile duct. Drawings show mass-forming (A), periductal-infiltrating (B), and intraductal-growing (C) cholangiocarcinomas.

 


View larger version (4K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1B. Morphologic classification of intrahepatic and extrahepatic cholangiocarcinoma. Tubule represents bile duct. Drawings show mass-forming (A), periductal-infiltrating (B), and intraductal-growing (C) cholangiocarcinomas.

 


View larger version (5K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 1C. Morphologic classification of intrahepatic and extrahepatic cholangiocarcinoma. Tubule represents bile duct. Drawings show mass-forming (A), periductal-infiltrating (B), and intraductal-growing (C) cholangiocarcinomas.

 

Mass-forming intrahepatic cholangiocarcinoma and infiltrating extrahepatic cholangiocarcinoma and their imaging findings are well described in the literature [7, 8, 15]; intraductal-growing cholangiocarcinoma, however, is not. In this review, I describe the gross appearance of intrahepatic and extrahepatic cholangiocarcinomas, correlate the pathologic and imaging findings, consider the mode of spread of these tumors, and discuss the clinical significance of the various growth patterns of cholangiocarcinoma.


Pathologic and Imaging Findings
Top
Introduction
Pathologic and Imaging Findings
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
Mode of Spread
Clinical Significance
References
 
Microscopically, most cholangiocarcinomas, approximately 90%, are adenocarcinomas. Glandular structures grow in cellular nests that are separated by fibrous stroma [1]. These tumors have a tendency to spread between the hepatocyte plates, along the duct walls, and adjacent to nerves [5]. Perineural invasion is frequent, found in as many as 81% of reported cases [16]. Results of mucin stains are nearly always positive, and mucin production is often abundant [1, 6].

In a study by Sasaki et al. [11], more than half of the mass-forming intrahepatic cholangiocarcinomas were poorly differentiated, whereas most periductal-infiltrating cholangiocarcinomas were well differentiated. Most intraductal-growing cholangiocarcinomas have been classified as papillary adenocarcinomas [17-20].


Intrahepatic Cholangiocarcinoma
Top
Introduction
Pathologic and Imaging Findings
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
Mode of Spread
Clinical Significance
References
 
Mass-Forming Type
A mass-forming intrahepatic cholangiocarcinoma is usually large, up to 15 cm in diameter. On gross specimens, the tumor is firm and whitish gray because of its large amount of fibrous stroma [5]. The margin is well circumscribed and wavy or lobulated (Fig. 2). Central necrosis may be present [15]. Multicentricity, especially around the main tumor, is common, probably because of the propensity of the tumor to invade the adjacent peripheral branches of the portal vein [5, 11, 20, 21].



View larger version (95K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 2. Mass-forming intrahepatic cholangiocarcinoma. Photograph of gross pathologic specimen shows whitish mass with extensive desmoplastic change. Margin is irregular but sharply circumscribed. Note peritumoral satellite masses (arrows). Also note small central hemorrhagic necrosis.

 

The most common appearance of peripheral intrahepatic cholangiocarcinoma on sonography, CT, and MRI is a well-defined, single, predominantly homogeneous mass with irregular borders [6, 15, 22, 23] (Fig. 3). Satellite or daughter nodules are frequent and vary in size [23] (Fig. 4). On contrast-enhanced CT or MRI, thin or thick, rimlike enhancement is frequently seen around the periphery of the tumor on arterial phase images and as gradual centripetal enhancement on delayed phase images [23-25] (Fig. 3). The entire mass may be enhanced only on delayed phase images, some hours after contrast administration. Some cholangiocarcinomas are depicted only on delayed phase images, and the tumors may be missed without them. These findings reflect the nature of the tumor, which is mainly desmoplastic. Capsular retraction is relatively frequent [23] (Fig. 3). The bile ducts peripheral to the tumor are usually dilated because of obstruction by the tumor. At other times, they may not be dilated, even if the tumor arises from one of the intrahepatic ducts [23].



View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 3. 58-year-old woman with mass-forming intrahepatic cholangiocarcinoma. CT scan shows lobulated tumor with sharp but irregularly rolled margin in right hepatic lobe.

 


View larger version (124K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 4. 57-year-old man with mass-forming intrahepatic cholangiocarcinomas. CT scan shows irregularly shaped mass with peripheral enhancement. Note three small peritumoral satellite nodules (arrow).

 

Imaging findings of mass-forming hilar cholangiocarcinomas appear basically the same as those of peripheral cholangiocarcinomas, except that they include intrahepatic bile duct dilatation [9, 26]. Most hilar cholangiocarcinomas result in obstruction of the right and left hepatic ducts, and a mass may override and separate the bile ducts [9, 26, 27].

Periductal-Infiltrating Type
Periductal-infiltrating cholangiocarcinoma grows along the bile ducts and is therefore elongated, spiculated, or branchlike (Fig. 5). Irregular narrowing of the involved bile duct eventually results in obstruction. Most hilar cholangiocarcinomas are of the periductalinfiltrating type, and it is therefore difficult or impossible to depict the tumor mass on CT and sonography [9, 26, 28].



View larger version (116K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 5. Periductal-infiltrating hilar cholangiocarcinoma. Photograph of resected left hepatic lobe shows infiltrating cancer along left hepatic duct (arrows). Scale increments are 5 mm.

 

On imaging, the bile ducts proximal to the cholangiocarcinoma are dilated and the involved bile ducts are diffusely narrow or obliterated (Figs. 6A, and 6B). Nonunion of the right and left hepatic ducts with or without a visible thickened wall is a typical finding of infiltrating hilar cholangiocarcinoma [9, 27, 29]. On cholangiography, the lumen may be completely obstructed or markedly narrowed (Figs. 6A, and 6B). A stringlike, severely narrow bile duct may be visualized [28].



View larger version (141K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6A. 55-year-old man with periductal-infiltrating intrahepatic and extrahepatic cholangiocarcinoma. Endoscopic retrograde cholangiogram shows diffuse narrowing (arrows) of right and left hepatic ducts and extrahepatic duct. Note complete obstruction of posterior segmental bile ducts of right lobe.

 


View larger version (135K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 6B. 55-year-old man with periductal-infiltrating intrahepatic and extrahepatic cholangiocarcinoma. CT scan obtained at portal venous phase shows left intrahepatic bile duct dilatation (curved arrow) and obliteration of bile ducts in right hepatic lobe and hepatic hilum. Ill-defined, branchlike, low-attenuating mass (straight arrows) represents periductal infiltrating intrahepatic cholangiocarcinoma.

 

Intraductal-Growing Type
Most intraductal-growing cholangiocarcinomas are papillary adenocarcinomas [17-20], comprising innumerable frondlike infoldings of proliferated columnar epithelial cells and slender fibrovascular cores [17]. The tumors are usually small, sessile, or polypoid, often spreading superficially along the mucosal surface and resulting in multiple tumors (papillomatosis) along various segments of the bile ducts [17-19]. Sometimes a large mass occludes the bile duct [18, 20] (Figs. 7A, and 7B, 7C). Occasionally, the tumor produces a profuse amount of mucus, resulting in partial biliary obstruction [17, 18, 20].



View larger version (121K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7A. 53-year-old man with intraductal growing intrahepatic cholangiocarcinoma. Contrast-enhanced CT scan shows aneurysmally dilated left hepatic bile ducts containing multiple fungating tumors and fluid in between. Peripheral bile ducts (arrow) are dilated.

 


View larger version (153K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7B. 53-year-old man with intraductal growing intrahepatic cholangiocarcinoma. Endoscopic retrograde cholangiogram shows diffuse dilatation of intraand extrahepatic bile ducts. Elongated filling defect in extrahepatic duct represents mucin (solid arrows). Note irregular filling defect in disproportionately dilated left intrahepatic duct representing fungating papillary tumor (open arrow).

 


View larger version (66K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 7C. 53-year-old man with intraductal growing intrahepatic cholangiocarcinoma. Photograph of gross pathologic specimen shows large fungating papillary tumors (arrow) in aneurysmally dilated intrahepatic bile duct. Bile duct wall has been thickened but not invaded by tumor. There was excessive mucin in bile ducts at surgery.

 

Papillary adenocarcinoma is a low-grade malignancy, often limited to the mucosa and invading the wall in the late phase [17]. Intraductal-growing cholangiocarcinoma is fairly common, accounting for 8-18% of reported cases [6-8]. In one series, it constituted 15% of all resected intrahepatic cholangiocarcinomas [18].

Bile ducts are dilated because of obstruction by a tumor, by sloughed tumor debris, or by an excessive amount of mucin [17]. The biliary tree is dilated diffusely, lobarly, or segmentally, somewhat reminiscent of bronchiectasis in the lung, or aneurysmally depending on the size of a tumor and the amount of mucin production [18, 20] (Figs. 7A, 7B, and 7C).

On sonography, CT, or MR cholangiography, the bile ducts of the involved hepatic segment or hepatic lobe are dilated. An intraductal mass can appear as an echogenic mass on sonography and as an enhancing soft-tissue mass on CT (Fig. 7A). The mass is confined within the bile ducts, and thus the wall of the bile duct remains intact. The outer margin of the thickened bile duct wall is smooth and clear. The tumor may not be depicted when it is small and isoattenuating to the adjacent hepatic parenchyma or when the complex orientation of the dilated bile ducts obscures the presence of the mass [7]. On endoscopic retrograde cholangiopancreatography or percutaneous transhepatic cholangiography, the involved biliary tree is dilated because of partial obstruction, and filling defects appear because of papillary tumors (Fig. 7B). There may be fine irregularities, a velvety or serrated contour along the bile ducts, representing the papillary surface of the tumor [17].

Intraductal Papillary Mucinous Tumor of the Bile Duct as a Variant
Some papillary tumors of the bile ducts produce a large amount of mucin [17, 18, 20] and may occasionally impede the flow of bile juice, whereupon obstructive jaundice occurs. Endoscopy may show mucin protruding from the patulous orifice of the duodenal papilla. This tumor bears a striking similarity to intraductal papillary tumor of the pancreas in terms of its histopathology, production of excessive mucin, and pathophysiology. Sonography, CT, and MR cholangiopancreatography show severe dilatation of the intraand extrahepatic ducts. Both proximal and distal bile ducts to the tumor are dilated because mucin may obstruct the papilla of Vater. On sonography and CT, the tumor may appear as a small mass.

Mucin is echo-free on sonography and water-attenuating on CT and therefore not visible. Endoscopic retrograde cholangiopancreatography or percutaneous transhepatic cholangiography can show large or small, elongated or amorphous filling defects caused by mucin in the dilated bile ducts [17] (Fig. 7B).

Some intrahepatic papillary mucinous tumors may produce aneurysmlike cystic dilatation of the bile ducts [17, 18, 20] that harbor multiple, fungating, intraductal papillary tumors (Fig. 7C). Some of the involved bile ducts dilate cystically, whereas others dilate diffusely and proportionally.

In short, mass-forming intrahepatic cholangiocarcinoma shows a large, well-defined, irregular mass with frequent satellite nodules, periductal-infiltrating cholangiocarcinoma results in obliteration of the bile ducts and proximal dilatation without an identifiable mass, and intraductal-growing cholangiocarcinoma presents with focal or segmental bile duct dilatation with or without visible intraductal papillary tumors.


Extrahepatic Cholangiocarcinoma
Top
Introduction
Pathologic and Imaging Findings
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
Mode of Spread
Clinical Significance
References
 
Cholangiocarcinoma can develop in any part of the extrahepatic duct, occurring in 50-75% of reported cases in the upper third of the duct including the hepatic hilum, in 10-25% in the middle third, and in 10-20% in the lower third [30-32]. Approximately 95% of cases show extrahepatic obstruction at the time of diagnosis [33]. Involvement of the periductal lymphatics, nerves, and perineural tissue is frequent [5].

Mass-Forming Type
The tumor forms a nodule, which is usually 1-2 cm in diameter. The tumor obstructs the bile duct lumen, penetrates the wall, and invades the periductal tissue [6]. The luminal surface is usually irregular [6].

On sonography, CT, MRI, MR cholangiography, or cholangiography, a mass-forming extrahepatic cholangiocarcinoma can be easily detected because the tumor occludes the bile duct and thus causes dilatation of the proximal bile ducts [27, 34] (Figs. 8A, 8B, and 8C). The bile ducts are usually completely obstructed at the time of diagnosis. Because the mass is generally small, images should be carefully scrutinized. On sonography, the mass may be masked by the surrounding soft-tissue structures or may be obscured by the adjacent bowel gas.



View larger version (132K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 8A. 71-year-old man with mass-forming extrahepatic cholangiocarcinoma. Endoscopic retrograde cholangiogram shows short segmental asymmetric narrowing due to mass (arrow) at common hepatic duct.

 


View larger version (137K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 8B. 71-year-old man with mass-forming extrahepatic cholangiocarcinoma. Tube cholangiogram via drainage catheter obtained 7 months after A shows amputation of common hepatic duct representing obstruction by tumor.

 


View larger version (151K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 8C. 71-year-old man with mass-forming extrahepatic cholangiocarcinoma. Sonogram of common hepatic duct shows nodular mass measuring 1.5 cm. Note obliteration of echogenic wall of common hepatic duct indicating periductal invasion.

 

Periductal-Infiltrating Type
The tumor appears as a diffuse, firm, gray-white, annular thickening of the extrahepatic ducts with almost complete obstruction of the lumen [6]. The thickness of the wall increases up to 1 cm [6]. Concentric layering of cellular stroma around the neoplastic glands is the most important identifying feature [5] (Fig. 9). The extent of the tumor varies, ranging from 0.5 to 6 cm in length, sometimes involving all the extrahepatic ducts and extending proximally as far as the intrahepatic ducts. Associated tumor formation may occur outside the bile ducts in the intrahepatic portion [33, 35, 36].



View larger version (52K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 9. Photomicrograph of histopathologic specimen from resected common hepatic duct shows well-differentiated adenocarcinoma replacing mucosa, submucosa, muscle layer (solid arrows), and serosa. Tumor spreads longitudinally along extrahepatic duct via lymphatics and perineural tissue, resulting in concentric layering of cellular stroma, neoplastic glands, and split muscle layers. Open arrows represent mucosal side. (H and E, x1)

 

On CT or MRI, the thickened bile ducts can be visualized as an enhancing ring or spot (Figs. 10A, 10B, and 10C). Sonography usually fails to depict the mass but shows focal or diffuse thickening of the bile duct [34]. The involved segment is variable, and the tumor border can be shown as an asymmetrically thickened bile duct wall at the transition zone [37] (Figs. 10A, 10B, and 10C). On cholangiography, the involved segment may not be opacified in cases of complete obstruction, or it may appear to be stringlike when the lumen is not completely obstructed (Figs. 10A, 10B, and 10C).



View larger version (136K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 10A. 61-year-old woman with periductal-infiltrating extrahepatic cholangiocarcinoma. Tube cholangiogram shows diffuse severe narrowing of extrahepatic duct.

 


View larger version (159K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 10B. 61-year-old woman with periductal-infiltrating extrahepatic cholangiocarcinoma. CT scan shows severe dilatation of extrahepatic duct and asymmetric thickening of wall (arrow).

 


View larger version (138K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 10C. 61-year-old woman with periductal-infiltrating extrahepatic cholangiocarcinoma. CT scan obtained through extrahepatic duct shows encircling wall-thickening with enhancement (arrow) and obliteration of lumen.

 

Intraductal-Growing Type
In this type, the intraductal tumor may be polypoid, sessile, or superficially spreading along the lumen [17-20] (Figs. 11A, 11B, and 11C). Discrete multiple tumors (cholangiocarcinomatosis) may be present along the inner surface of the bile ducts. Usually the tumor is limited to the mucosa and invades the wall and the surrounding tissue in the very late phase [17]. Intraductal papillary cholangiocarcinoma is friable and sloughs easily when it is touched or rubbed at the time of surgery. It can also slough spontaneously and, simulating bile duct stones, occlude the bile ducts [17].



View larger version (116K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 11A. 72-year-old man with intraductal-growing intra- and extrahepatic papillary cholangiocarcinomatosis. Contrast-enhanced CT scan shows asymmetric thickening of bile duct wall (arrow) and intraluminal mass representing tumor.

 


View larger version (109K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 11B. 72-year-old man with intraductal-growing intra- and extrahepatic papillary cholangiocarcinomatosis. Tube cholangiogram shows severe irregularity and tiny filling defects in right and left hepatic ducts as well as extrahepatic ducts representing papillary carcinomatosis (arrows).

 


View larger version (143K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 11C. 72-year-old man with intraductal-growing intra- and extrahepatic papillary cholangiocarcinomatosis. Photograph of cholangioscopic finding shows tiny, innumerable masses in lumen of bile ducts.

 

On imaging, the bile ducts proximal to the tumor are dilated, the degree of dilatation depending on the degree of obstruction. The intraductal tumor is depicted as a castlike or sessile mass on sonography, CT, or MR cholangiography [17]. Usually the tumor is small and flat, but occasionally it is large. The tumor tends to spread superficially along the lumen for a variable length and sometimes implants along the inner surface of the bile ducts, creating multiple discrete tumors [19] (Figs. 11A, 11B, and 11C). Cholangiography shows intraductal tumor or irregularity of the bile duct wall. Because the intraductal papillary tumor does not penetrate the bile duct wall, its outer margin is clear on sonography as well as on CT. Radiologic findings are basically the same as those for the intrahepatic intraductal form.

In short, mass-forming extrahepatic cholangiocarcinoma results in bile duct obstruction by a small mass; periductal-infiltrating cholangiocarcinoma produces segmental or diffuse, concentric thickening of the wall of the bile ducts without a focal mass; and intraductal-growing cholangiocarcinoma produces bile duct dilatation with single or multiple papillary intraductal masses.


Mode of Spread
Top
Introduction
Pathologic and Imaging Findings
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
Mode of Spread
Clinical Significance
References
 
Mass-Forming Cholangiocarcinoma
Intrahepatic cholangiocarcinoma arises from the mucosa of a branch of the bile ducts in the peripheral or hilar area of the liver, invades and penetrates the bile duct wall, spreads between hepatocyte plates, expands via the hepatic sinusoidal spaces [1], and grows three dimensionally. Similar to hepatocellular carcinomas, tumor cells have a propensity to invade small portal venous branches adjacent to the primary mass as a portal venous tumor thrombus [1, 5, 6, 11, 21]. As the primary mass and adjacent satellite tumors within the portal vein grow, they fuse together and form a large mass (Figs. 12A, and 12B). Therefore, the tumor margin is usually irregular, rolled, or lobulated.



View larger version (6K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 12A. Growing patterns of intrahepatic mass-forming cholangiocarcinoma. Drawings show main tumor and peritumoral satellite nodules caused by portal vein tumor thrombosis (A) and growth of tumor caused by fusion of growing satellite nodules (B).

 


View larger version (34K):
[in this window]
[in a new window]
[as a PowerPoint slide]
 
Fig. 12B. Growing patterns of intrahepatic mass-forming cholangiocarcinoma. Drawings show main tumor and peritumoral satellite nodules caused by portal vein tumor thrombosis (A) and growth of tumor caused by fusion of growing satellite nodules (B).

 

Tumors arising from the mucosa of the extrahepatic duct grow intraluminally, invade the bile ductal wall, and eventually penetrate to the serosa [5, 6]. Because the intraluminal tumors easily occlude the lumen and cause obstructive jaundice at a relatively early stage, tumors of the extrahepatic ducts are small at the time of diagnosis, usually less than 2 cm.

Periductal-Infiltrating Cholangiocarcinoma
Cholangiocarcinoma arising from the mucosa of the intrahepatic bile ducts invades the wall and penetrates to the serosa [6]. In contrast to mass-forming cholangiocarcinoma, periductal-infiltrating cholangiocarcinoma tends to spread along the bile duct wall via the nerve and perineural tissue of Glisson's capsule toward the porta hepatis [1, 6]. Occasionally, a substantial portion of the tumor tumor extends beneath the intact mucosal epithelium [6]. Thus, the tumor grows longitudinally and extends along the axis of the bile duct like a branch of a tree [4]. Extrahepatic periductal infiltrating tumor is characterized by concentric thickening of the bile duct wall (the length of the thickening varies) [5, 6] (Fig. 9); it does not produce a sizable mass.

Intraductal-Growing Cholangiocarcinoma
In intraductal-growing papillary cholangiocarcinomas, tumor cells are confined within the mucosal layer and do not invade deep into the submucosal layer; the tumor then spreads superficially along the mucosal layer. Because the intraluminal papillary projections are slender and long, the tumor is friable and may slough spontaneously [17]. Sometimes, the detached tumor implants at the lumen of the adjacent bile duct, resulting in multiple tumors (papillomatosis) (Figs. 11A, 11B, and 11C).

It is postulated that when a tumor grows to a certain size, it sloughs spontaneously from the wall of the bile ducts. The sloughed and floating tumor debris may reside within the bile ducts, imbibing nutrients from the bile juice, and may grow substantially. These sizable tumors then float within the bile ducts and partially occlude the bile flow, or they may drain through the orifice of the papilla of Vater [17]. A similar phenomenon is also well known: hepatocellular carcinoma can be detached from the bile duct and grow within the bile ducts as an embolus [38, 39].


Clinical Significance
Top
Introduction
Pathologic and Imaging Findings
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
Mode of Spread
Clinical Significance
References
 
Morphologic classification of cholangiocarcinoma is useful for understanding the biological behavior of this tumor as well as for planning and choosing the appropriate treatment and for predicting prognosis [13, 14].

The surgical treatment should be tailored according to the gross morphology of the cholangiocarcinoma. To achieve a permanent cure, physicians should perform liver resection with a tumor-free margin in cases of the mass-forming type; but for cholangiocarcinomas of the periductal-infiltrating type, more aggressive surgery, including extensive liver resection, lymph node dissection, and adjuvant anticancer therapy, should be performed [12, 40]. For intraductal-growing cholangiocarcinomas, tumor resection with a tumor-free margin is sufficient, and long-term patient survival can be expected [17-19].


Acknowledgments
 
I thank Cheol Keun Park for his invaluable advice regarding the pathology of cholangiocarcinoma and Bonnie Hami and Young Joo Moon for copyediting the manuscript.


References
Top
Introduction
Pathologic and Imaging Findings
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
Mode of Spread
Clinical Significance
References
 

  1. Nakajima T, Kondo Y, Miyazaki M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: histologic classification and mode of spreading. Hum Pathol1988; 19:1228 -1234[Medline]
  2. Edmondson HA. Tumors of the liver and intrahepatic bile ducts: atlas of tumor pathology, sec 7, fasc. 25 Washington, DC: Armed Forces Institute of Pathology, 1958
  3. Clemett AR. Carcinoma of the major bile ducts. Radiology 1985;84:894 -903
  4. Eggel H. Uber das primare Carcinoma der Leber. Beitr Pathol Anat Allg Pathol1901; 30:506 -604
  5. Rosai J. Ackerman's surgical pathology, 8th ed. St. Louis: Mosby, 1996: 914-915, 960
  6. Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol 1983;139:217 -238[Medline]
  7. Lee WJ, Lim HK, Jang KM, et al. Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnosis. RadioGraphics2001; 21:97 -116
  8. Robledo R, Muro A, Prieto ML. Extrahepatic bile duct carcinoma: US characteristics and accuracy in demonstration of tumors. Radiology1996; 198:869 -873[Abstract/Free Full Text]
  9. Choi BI, Lee JH, Han MC, Kim SH, Yi JG, Kim CW. Hilar cholangiocarcinoma: comparative study with sonography and CT. Radiology1989; 172:689 -692[Abstract/Free Full Text]
  10. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer, 4th ed. Tokyo: Kanehara, 2000
  11. Sasaki A, Aramaki M, Kawano K, et al. Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment. Br J Surg 1998;85:1206 -1209[Medline]
  12. Yamamoto M, Takasaki K, Yoshikawa T, Ueno K, Nakano M. Does gross appearance indicate prognosis in intrahepatic cholangiocarcinoma? J Surg Oncol 1998;69:162 -167[Medline]
  13. Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999;6:108 -116[Medline]
  14. Sano T, Kamiya J, Nagino M, et al. Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinomas in Japan. J Hepatobiliary Pancreat Surg1999; 6:101 -107[Medline]
  15. Ros PR, Buck JL, Goodman ZD, Ros AMV, Olmsted WW. Intrahepatic cholangiocarcinoma: radiologicpathologic correlation. Radiology1988; 167:689 -693[Abstract/Free Full Text]
  16. Bhuiya MR, Nimura Y, Kamiya J, et al. Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg1992; 215:344 -349[Medline]
  17. Lim JH, Yi C, Lim HK, et al. Radiological spectrum of intraductal papillary tumors of the bile ducts. Korean J Radiol2002; 3:57 -63[Medline]
  18. Lee JW, Han JK, Kim TK, et al. CT features of intraductal intrahepatic cholangiocarcinoma. AJR2000; 175:721 -725[Abstract/Free Full Text]
  19. Kim YS, Myung ST, Kim SY, et al. Biliary papillomatosis: clinical, cholangiographic and cholangioscopic findings. Endoscopy 1998;30:763 -767[Medline]
  20. Yoon KH, Han HK, Kim CG, et al. Malignant papillary neoplasms of intrahepatic bile ducts: CT and histopathologic features. AJR 2000;175:1135 -1139[Abstract/Free Full Text]
  21. Terada T, Kida T, Nakanuma Y, Noguchi T. Extensive portal tumor thrombi with portal hypertension in an autopsy case of intrahepatic cholangiocarcinoma. Am J Gastroenterol1991; 87:1513 -1518
  22. Choi BI, Park JH, Kim YI, et al. Peripheral cholangiocarcinoma and clonorchiasis: CT findings. Radiology1988; 169:149 -153[Abstract/Free Full Text]
  23. Kim TK, Choi BI, Han JK, Jang HJ, Cho SG, Han MC. Peripheral cholangiocarcinoma of the liver: two-phase helical CT findings. Radiology1997; 204:539 -543[Abstract/Free Full Text]
  24. Soyer P, Bluemke DA, Reichle R, et al. Imaging of intrahepatic cholangiocarcinoma. 1 Peripheral cholangiocarcinoma. AJR 1995;165:1427 -1431[Abstract/Free Full Text]
  25. Honda H, Onitsuka H, Yasumori K, et al. Intrahepatic peripheral cholangiocarcinoma: two-phased dynamic incremental CT and pathological correlation. J Comput Assist Tomogr1993; 17:397 -402[Medline]
  26. Soyer P, Bluemke DA, Reichle R, et al. Imaging of intrahepatic cholangiocarcinoma. 2 Hilar cholangiocarcinoma. AJR1995; 165:1433 -1436[Abstract/Free Full Text]
  27. Hann LE, Greatrex KV, Bach AM, Fong Y, Blumgart LH. Cholangiocarcinoma at the hepatic hilus: sonographic findings. AJR 1997;168:985 -989[Abstract/Free Full Text]
  28. Han JK, Choi BI, Kim TK, Kim SH, Han MC, Yeon KM. Hilar cholangiocarcinoma: thin-section spiral CT findings with cholangiographic correlation. RadioGraphics1997; 17:1475 -1485[Abstract]
  29. Robledo R, Muro A, Prieto ML. Extrahepatic bile duct carcinoma: US characteristics and accuracy in demonstration of tumors. Radiology1996; 198:869 -873
  30. Alexander F, Rossi RL, O'Bryan M, Khettry U, Braasch JW, Walkins E Jr. Biliary carcinoma: a review of 109 cases. Am J Surg 1984;147:503 -509[Medline]
  31. Okuda K, Kubo Y, Okazaki N, et al. Clinical aspect of intrahepatic bile duct carcinoma including hilar carcinoma: a study of 57 autopsy-proven cases. Cancer1977; 39:232 -246[Medline]
  32. Elias E, Hamlyn AN, Jain S, Long RG, Summerfield JA, Sherlock S. A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology1976; 71:439 -443[Medline]
  33. Desa LA, Akosa AB, Lazzara S, Domizio P, Krausz T, Benjamin IS. Cytodiagnosis in the management of extrahepatic biliary stricture. Gut 1991;32:1188 -1191[Abstract/Free Full Text]
  34. Baron RL, Stanley RJ, Lee JKT, et al. A prospective comparison of the evaluation of biliary obstruction using computed tomography and ultrasonography. Radiology1982; 145:91 -98[Abstract/Free Full Text]
  35. Beazley RM, Hadjis N, Benjamin IS, Blumgart LH. Clinicopathological aspects of high bile duct cancer: experience with resection and bypass surgical treatments. Ann Surg1984; 199:623 -636[Medline]
  36. Hayashi S, Miyazaki M, Kondo Y, Nakajima N. Invasive growth patterns of hepatic hilar ductal carcinoma: a histologic analysis of 18 surgical cases. Cancer1994; 73:2922 -2929[Medline]
  37. Schulte SJ, Baron RL, Teefey SA, et al. CT of the extrahepatic bile ducts: wall thickness and contrast enhancement in normal and abnormal ducts. AJR 1990;154:79 -85[Abstract/Free Full Text]
  38. Kiev J, Dyslin DC, Vitenas P Jr, Kerstein MD. Obstructive jaundice caused by hepatoma fragments in the common bile duct. J Clin Gastroenterol 1990;12:207 -213[Medline]
  39. Buckmaster MJ, Schwartz RW, Carnahan GE, Strodol WE. Hepatocellular carcinoma embolus to the common hepatic duct with no detectable primary hepatic tumor. Am Surg1994; 60:699 -702[Medline]
  40. Ohashi K, Nakajima Y, Tsutsumi M, et al. Clinical characteristics and proliferating activity of intrahepatic cholangiocarcinoma. J Gastroenterol Hepatol 1994;9:442 -446[Medline]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
J. H. Lim, K.-T. Jang, and D. Choi
Biliary Intraductal Papillary-Mucinous Neoplasm Manifesting Only as Dilatation of the Hepatic Lobar or Segmental Bile Ducts: Imaging Features in Six Patients
Am. J. Roentgenol., September 1, 2008; 191(3): 778 - 782.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
H. S. Park, J. M. Lee, S. H. Kim, J. Y. Jeong, Y. J. Kim, K. H. Lee, S. H. Choi, J. K. Han, and B. I. Choi
CT Differentiation of cholangiocarcinoma from periductal fibrosis in patients with hepatolithiasis.
Am. J. Roentgenol., August 1, 2006; 187(2): 445 - 453.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. H. Lim, K.-T. Jang, D. Choi, W. J. Lee, and H. K. Lim
Early Bile Duct Carcinoma: Comparison of Imaging Features with Pathologic Findings
Radiology, February 1, 2006; 238(2): 542 - 548.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
H.-X. Xu, M.-D. Lu, G.-J. Liu, X.-Y. Xie, Z.-F. Xu, Y.-L. Zheng, and J.-Y. Liang
Imaging of Peripheral Cholangiocarcinoma With Low-Mechanical Index Contrast-Enhanced Sonography and SonoVue: Initial Experience
J. Ultrasound Med., January 1, 2006; 25(1): 23 - 33.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
J. H. Lim, K.-H. Yoon, S. H. Kim, H. Y. Kim, H. K. Lim, S. Y. Song, and K. J. Nam
Intraductal Papillary Mucinous Tumor of the Bile Ducts
RadioGraphics, January 1, 2004; 24(1): 53 - 66.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lim, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lim, J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH